Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Buy
78,999
+3,633
+5% +$411K ﹤0.01% 2095
2026
Q1
$8.39M Buy
75,366
+12,524
+20% +$1.48M ﹤0.01% 2145
2025
Q4
$8.47M Buy
62,842
+33,595
+115% +$3.67M ﹤0.01% 2073
2025
Q3
$2.48M Buy
+29,247
New +$1.79M ﹤0.01% 3118

Other funds holding ABVX

LPL Financial's ABVX Position: Q2 2026 in Review

LPL Financial increased its Abivax (ABVX) stake by 4.8% in Q2 2026, buying an estimated $411K and bringing the position to 78,999 shares worth $10.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2095.

LPL Financial first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 111 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • LPL Financial held 78,999 shares of Abivax worth $10.5M as of Q2 2026.
  • LPL Financial bought 3,633 Abivax shares in Q2 2026, an estimated $411K.
  • Abivax made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #2095 holding.
  • LPL Financial first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 111 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.